What Health Screenings Should You Actually Get in Your 30s and 40s?

Search “health screenings by age” and you get a chart: something for every decade, evenly spaced, implying a steady drumbeat of tests from your 20s onward. The actual guidance is lumpier than that. A handful of screenings have a task force’s strongest possible grade behind them. A few sit right at the edge of your 30s or 40s because the recommended starting age moved recently. And at least two things people routinely get checked — a skin exam, a thyroid panel — have no general recommendation behind them at all, for reasons worth understanding rather than shrugging off.

The short list that actually has backing

The U.S. Preventive Services Task Force is the body that grades preventive care in the way this matters: not “is this test useful in some circumstance” but “does population-level evidence show the benefit clearly outweighs the harm for people without symptoms.” Grade A and Grade B recommendations pass that bar. An “I” grade means the evidence isn’t there yet to say either way — not that the test is useless, just that nobody has shown it clears the bar.

That table is the whole guide, compressed. Everything below is what sits behind each row.

Blood pressure: the one with no age floor

Blood pressure screening starts at 18 and never stops, because it costs nothing beyond a cuff and a few minutes, and hypertension has no symptoms until it has caused damage. The Task Force’s current recommendation calls for office measurement at every visit, with any elevated reading confirmed outside the clinic before treatment starts — a single high number at a nervous appointment isn’t a diagnosis on its own.

The numbers that turn a reading into a label: normal sits under 120/80 mmHg, and a consistent reading of 130/80 or higher counts as hypertension. The gap between those two figures, 120-129 over under 80, is labelled elevated — not yet hypertension, but not the number you want to plateau at through your 30s and 40s.

Cholesterol stops being its own test in your 40s

This is the one that surprises people: current guidance doesn’t ask “is your cholesterol high” as a standalone question once you’re 40. It asks for a ten-year cardiovascular risk calculation — built from the ACC/AHA Pooled Cohort Equations — that folds cholesterol in alongside blood pressure, diabetes status, smoking history and age. A statin is recommended for adults 40-75 who have at least one risk factor and a calculated ten-year risk of 10% or higher.

The uncomfortable part is that this means two people with an identical cholesterol number can land on opposite sides of a screening recommendation, because the number was never the whole calculation. A lipid panel still gets drawn, but treat it as an input to a formula, not a verdict on its own.

Diabetes screening starts at 35 now, with a condition attached

The starting age for prediabetes and type 2 diabetes screening dropped from 40 to 35, but only for adults who carry overweight or obesity — a BMI of 25 or higher, or 23 or higher for Asian American adults, per the current recommendation. If that doesn’t describe you, the guideline doesn’t specify a starting age at 35 on the same terms; a clinician may still test earlier for other risk factors, but the population-level recommendation is conditional, not universal.

This matters because “diabetes screening starts at 35” gets repeated as a flat rule online, and the qualifier drops out in the retelling. It’s exactly the kind of detail that changes what you should ask for at an appointment.

Colorectal cancer screening starts at 45, not 50

This one moved recently and moved cleanly: the Task Force now grades ages 45-49 at B and keeps 50-75 at A, its strongest grade. If you’re in your late 40s and have never had this conversation with a clinician, that’s the gap — not a lapse on your part, but a recommendation that changed after a lot of people’s mental checklist was already set.

The accepted options aren’t limited to colonoscopy. A stool-based test done more frequently is an accepted alternative under the same recommendation, and which one suits you is a genuinely personal call — access, prior findings and how you feel about the two approaches all belong in that decision.

Cervical cancer screening doesn’t pause through your 30s

Ages 21-29 get a grade A recommendation for cytology (a Pap smear) every three years. From 30 to 65, the options widen: cytology every three years, high-risk HPV testing every five years, or both together (co-testing) every five years — all graded A. None of these intervals shorten with age inside that range; the recommendation treats a 32-year-old and a 62-year-old the same way as long as prior results have been unremarkable.

Mammography starts at 40, and it’s every two years

This is a recent shift worth naming directly: mammography for average-risk women now starts at 40, at a grade B, rather than being an individual decision in your 40s and a firmer recommendation from 50 as it once was. The interval specified is every two years, not annually — a detail that surprises people who assume more frequent means safer, when the guideline was built around the interval that showed the best balance of benefit and harm at the population level.

The one-time tests almost nobody remembers

HIV and hepatitis C share a structure that’s easy to miss: both are recommended as a baseline test, once, for essentially everyone in the relevant age range — 15 to 65 for HIV, 18 to 79 for hepatitis C — regardless of how you’d rate your own risk. That design exists because risk-based testing (only test people who report risk factors) was found to miss cases in people who either didn’t disclose a risk factor or didn’t have one that fit the usual categories. Both infections can sit silently for years, which is exactly the situation a one-time, everyone-gets-it baseline is built to catch. If you’ve never had either test and can’t remember being offered one, that’s a real gap rather than something you can assume was already covered by other blood work.

Where popular advice outruns the evidence

Two screenings people expect to be on this list aren’t, and it’s worth being direct about why. Routine visual skin examination by a clinician, in someone with no complaint, carries an insufficient-evidence rating — not a recommendation against it, but an honest statement that nobody has shown the benefit clearly outweighs the harm at a population level. The same “I” grade applies to screening asymptomatic, non-pregnant adults for thyroid dysfunction, a rating that has stood since the Task Force’s 2015 review and its 2004 review before that.

Neither of these means skip a mole that’s changed shape, or ignore fatigue that’s actually a symptom — those aren’t screening scenarios, they’re a person reporting something. The distinction is between testing everyone as routine and testing someone who has already noticed a reason to ask. The first is what carries a grade; the second is ordinary medicine and doesn’t need one.

What this actually means for your decade

Nothing above is annual by default except blood pressure. The rest cluster around specific ages — 35, 40, 45 — that don’t line up neatly with a birthday, and several of them shifted in the last five years in ways that make an older mental checklist quietly out of date. The practical version: know which of your specific numbers (age, weight, prior results) puts you inside or outside each row in that table, and bring the ones that apply to your next visit rather than assuming a general physical automatically covers them. A checkup is not, by itself, a guarantee that any specific screening happened during it.